J 2022

Primary Lymphomas of the Breast: A Review

JAMES, Emily R, Roberto N MIRANDA and Suzanne Dawn TURNER

Basic information

Original name

Primary Lymphomas of the Breast: A Review

Authors

JAMES, Emily R, Roberto N MIRANDA and Suzanne Dawn TURNER (826 United Kingdom of Great Britain and Northern Ireland, guarantor, belonging to the institution)

Edition

JPRAS OPEN, 2022, 2352-5878

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

Netherlands

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 1.400

RIV identification code

RIV/00216224:14740/22:00128813

Organization unit

Central European Institute of Technology

UT WoS

000905546000018

Keywords in English

breast lymphoma; breast implant lymphoma; BIA-ALCL; non-Hodgkin lymphoma; breast implants

Tags

Tags

International impact, Reviewed
Změněno: 6/3/2023 17:54, Mgr. Pavla Foltynová, Ph.D.

Abstract

V originále

Lymphomas of the breast are rare neoplasms that arise from breast lymphoid tissue and are characterised by neoplastic B or T cells. Breast lymphomas arising from B cells include, but are not limited to, diffuse large B cell lymphoma, follicular lymphoma, extra-nodal marginal zone lymphoma and Burkitt lymphoma. Anaplastic large cell lymphoma (ALCL) is of a T cell origin and both anaplastic lymphoma kinase (ALK)-positive and ALK-negative presentations have been noted in the breast. In addition, there is a more recently identified presentation of ALK-negative ALCL that arises around textured breast implants and is usually confined to a periprosthetic fibrous capsule. Here, we discuss the clinical presentations, histological and immunohistochemical features and treatment options for each type of primary breast lymphoma. We hope that this review will highlight the importance of the timely and accurate diagnosis of breast lymphoma in order to tailor the most appropriate treatment. We also wish to raise awareness of the breast implantassociated lymphomas, with the goal of stimulating work that will aid our understanding of their epidemiology and pathogenesis.